Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization
- 27 February 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (6), 1441-1446
- https://doi.org/10.1016/j.bmcl.2004.01.022
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variantsBioorganic & Medicinal Chemistry Letters, 2003
- Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?Expert Opinion on Investigational Drugs, 2003
- 5 Inhibitors of Hepatitis C Virus NS3•4A Protease: An Overdue Line of TherapyProgress in Medicinal Chemistry, 2002
- Enantiopure Preparation of the Two Enantiomers of the Pseudo-C2-Symmetric N,N-Dibenzyl-1,2:4,5-diepoxypentan-3-amineThe Journal of Organic Chemistry, 2001
- Substrate Specificity of the Hepatitis C Virus Serine Protease NS3Journal of Biological Chemistry, 1997
- Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostereJournal of Medicinal Chemistry, 1993
- A method for the stereoselective synthesis of peptidyl trifluoromethyl ketonesTetrahedron Letters, 1992
- Synthesis of peptidyl fluoromethyl ketones and peptidyl .alpha.-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin GJournal of Medicinal Chemistry, 1990
- Fluorine-containing organozinc reagents. IV.: Reformatskii-type reactions of chlorodifluoroacet1c acid derivativesTetrahedron Letters, 1988
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967